Statins use and prognosis in lung cancer patients treated with immune checkpoint inhibitors: evidence from a meta-analysis
Dandan Liang, Qinghua Liu, Min Liu, Yi Li · 2026
Read Statins use and prognosis in lung cancer patients treated with immune checkpoint inhibitors: evidence from a meta-analysis by Dandan Liang, Qinghua Liu, Min Liu, Yi Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13575920.txt.
Description
Dandan Liang, Qinghua Liu, Min Liu, and Yi Li pool past studies in a 2026 paper on lung cancer care. New immune drugs have improved survival for many patients with advanced disease, but a large share still respond poorly to those drugs alone. Cholesterol lowering pills, called statins, may help the immune system fight tumors, based on early lab work.
Clinic data on that idea have pointed in mixed directions. The pooled analysis asks whether patients who took statins fared better while on immune drugs than patients who did not. The answer matters for a cheap, widely used pill that could be added to care if the benefit proves real.
Catalog record
| CREATOR | Dandan Liang, Qinghua Liu, Min Liu, Yi Li |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |